Medtronic plc

MDT · Large cap · 2 articles

Financial highlights

Metric	FY 04/25/25	FY 04/26/24	FY 04/28/23	FY 04/29/22	FY 04/30/21
Income Statement
Revenue	$33.5B	$32.4B	$31.2B	$31.7B	$30.1B
Cost of revenue	$11.6B	$11.2B	$10.7B	$10.1B	$10.5B
Selling, general & administrative	$10.8B	$10.7B	$10.4B	$10.3B	$10.1B
Research and development	$2.7B	$2.7B	$2.7B	$2.7B	$2.5B
Operating income	$6.0B	$5.1B	$5.5B	$5.8B	$4.5B
Interest expense	$729.0M	$719.0M	$636.0M	$553.0M	$925.0M
Pretax income	$5.6B	$4.8B	$5.4B	$5.5B	$3.9B
Income tax expense	$936.0M	$1.1B	$1.6B	$456.0M	$265.0M
Net income	$4.7B	$3.7B	$3.8B	$5.0B	$3.6B
Balance Sheet
Cash and equivalents	$2.2B	$1.3B	$1.5B	$3.7B	$3.6B
Current assets	$23.8B	$21.9B	$21.7B	$23.1B	$22.5B
Total assets	$91.7B	$90.0B	$90.9B	$91.0B	$93.1B
Current liabilities	$12.9B	$10.8B	$9.1B	$12.4B	$8.5B
Total liabilities	$43.4B	$39.6B	$39.3B	$38.3B	$41.5B
Total debt	$28.7B	$25.2B	$24.6B	$24.3B	$26.6B
Stockholders' equity	$48.0B	$50.2B	$51.5B	$52.6B	$51.4B
Cash Flow Statement
Cash from operations	$7.0B	$6.8B	$6.0B	$7.3B	$6.2B
Depreciation and amortization	$2.9B	$2.6B	$2.7B	$2.7B	$2.7B
Stock-based compensation	$429.0M	$393.0M	$355.0M	$359.0M	$344.0M
Capital expenditure	$1.9B	$1.6B	$1.5B	$1.4B	$1.4B
Free cash flow	$5.2B	$5.2B	$4.6B	$6.0B	$4.9B
Dividends paid	$3.6B	$3.7B	$3.6B	$3.4B	$3.1B
Share repurchases	$3.2B	$2.1B	$645.0M	$2.5B	$652.0M
Impairments	$0	$371.0M	$0	$515.0M	$0

Shares outstanding 1.3B · Free float 9.7%

Annual filing data through FY ended April 25, 2025; float as of July 4, 2026.